Publications:418
Vahram Haroutunian, PhD
About Me
Dr. Haroutunian joined the faculty at The Mount Sinai School of Medicine in the summer of 1982 and is Professor of Psychiatry and Neuroscience. Dr. Haroutunian came to Mount Sinai after completing a postdoctoral training program at Princeton concentrating on research in development in aging. His research interests since joining the Mount Sinai faculty have centered on the neurobiology of Alzheimer’s disease, successful aging and schizophrenia. He directs the Mount Sinai NIH Neurobiobank and the Alzheimer’s Disease Research Center Neuropathology Core. Dr. Haroutunian is Principal Investigator on over 10 different NIH grants and contracts. He is also the Associate Director for Research for the Veterans Administration Mental Illness Research and Education Clinical Center. Dr. Haroutunian’s research interests include gene and protein expression at the single cell level in health and disease; development of novel approaches for the study of the human brain, including laser capture microdissection, digital neuropathology, application of artificial intelligence to reveal pathological and neuroanatomical features not immediately appreciated by the human eye. Dr. Haroutunian’s lab collaborates extensively the laboratories of Dr. Panagiotis Roussos, Dr. Bin Zhang, and Dr. Pavel Katsel.
Language
English
Position
PROFESSOR | Psychiatry, PROFESSOR | Neuroscience
Research Topics
Aging, Alzheimer's Disease, Gene Expressions, Myelination, Neurotransmitters, Post-Transcriptional Processing, Prefrontal Cortex, Psychiatry, RNA, Schizophrenia
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Education
PhD, Kent State University
, Princeton University
Publications
Selected Publications
- Multi-omic expression of the VEGF family relates to Alzheimer's disease across diverse populations. Julia B. Libby, Kacie D. Deters, Nilüfer Ertekin-Taner, Minerva M. Carrasquillo, Mariet Allen, Philip De Jager, Vilas Menon, Bin Zhang, Vahram Haroutunian, Allan I. Levey, Nicholas T. Seyfried, Rima Kaddurah-Daouk, Steve Finkbeiner, Daifeng Wang, Anna K. Greenwood, Abby Vander Linden, Laura Heath, William L. Poehlman, Logan Dumitrescu, Vladislav A. Petyuk, David A. Bennett, Julie A. Schneider, Lisa L. Barnes, Timothy J. Hohman. Alzheimer's and Dementia
- Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures. Him K. Shrestha, Huan Sun, Jay M. Yarbro, Dong Geun Lee, Danting Liu, Erming Wang, Meghan McReynolds, Nan Zhang, Boer Xie, Shu Yang, Kaiwen Yu, Suresh Poudel, Yuxin Li, Zuo Fei Yuan, Dehui Kong, Minghui Wang, Zhen Wang, Mingming Niu, Hong Wang, Masihuz Zaman, Ju Wang, David R. Vanderwall, Yu Sun, Zhiping Wu, Ping Chung Chen, Bing Bai, Anthony A. High, Júlia Faura, Chunyu Liu, David A. Bennett, Erik C.B. Johnson, Nicholas T. Seyfried, Allan I. Levey, Vahram Haroutunian, Geidy E. Serrano, Thomas G. Beach, Michael DeTure, Takahisa Kanekiyo, Ronald C. Petersen, Guojun Bu, Pamela J. McLean, Dennis W. Dickson, Rosa Rademakers, Gang Yu, Xusheng Wang, Bin Zhang, Junmin Peng. Cell
- Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease. Qi Zeng, Minghui Wang, Erming Wang, Xianxiao Zhou, Peng Xu, Vahram Haroutunian, Dongming Cai, Bin Zhang, Kenneth Spicer, Crystal Flynn Longmire, Jacobo Mintzer, Yaneicy Gonazalez Rojas, V. Sotelo, William Hu, Floyd Jones, Amy Saklad, Sudha Seshadri, Amy Boegel, Sydni Jenee Hill, Paul Newhouse, Rebecca Long, Campbell Long, Arthur Williams, Allison Acree, Olga Brawman-Mintzer, Chelsea Reichert, Vita Pomara, Raymundo Hernando, Nunzio Pomara, Skieff Acothley, Nadeen Elayan, Micah Ellis Slaughter, Angelica Garcia, Marwan Sabbagh, Maushami Gurung, Richard Le, Joseph Masdeu, Christina Rosario, Caroline Smith, Teresa Kalowsky, Edgardo Rivera, Hamid Okhravi, Rebecca Devine, Meagan Yong, Emily Roglaski, Nasrin Ghesani, Mary Sano, Laili Soleimani, Judith Neugroschl, Hillel Grossman. GeroScience
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Haroutunian has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.